Our present findings proposed a model revealing that p-JNK2 and JNK2 contributed significantly to the switch between EMT and MET process (Figure 7) by regulating the expression of Fra1 through governing the presence of c-Jun and Jun-B in breast cancer. Here, JUN is linked to breast cancer.